DOP48 Amiselimod, a selective S1P receptor modulator in Crohn’s disease patients: a proof-of-concept study

Authors :: Toshifumi Hibi
Mamoru Watanabe
Martin Davies
Silvio Danese
G R D’Haens
Source :: Journal of Crohn's and Colitis. 13:S055-S056
Publication Year :: 2019
Publisher :: Oxford University Press (OUP), 2019.

Subjects :: Crohn's disease
business.industry
Proof of concept
Sphingosine-1-phosphate receptor
Gastroenterology
Cancer research
Medicine
General Medicine
business
medicine.disease

Tools